Aspen’s offer to cut prices of cancer drugs allows it to avoid EU fine

The EU executive is concerned that Aspen may have charged excessive prices for drugs mainly used to treat leukaemia and other haematological cancers

Eli Lilly CFO Josh Smiley resigns after ‘inappropriate’ communications

Investigation reveals consensual though inappropriate personal communications with staff

Sales of SA’s vitamins and nutritional supplements boom

SPONSORED | Vital Health Foods provides staff with vitamins and supplements as part of its wellness campaign

BioNTech study shows UK virus mutations in samples from March

The rise of new coronavirus strains has prompted calls for vaccinating people more quickly before mutations can become widespread

Netcare says strain of Covid-19 second wave was more severe

Covid-19 continues to weigh on the group, which says it had more pandemic patients in the three months to end-December than in the prior seven

DNA-testing firm 23andMe goes public via Branson-backed SPAC

CEO Anne Wojcicki says Covid-19 has opened doors to more health-care products including genetic data

BioNTech fund pays €600m to early backers after vaccine success

MIG has provided funding to the German biotech company, which developed the vaccine with US drugmaker Pfizer, since 2008

Merck CEO Kenneth Frazier announces retirement after a decade at the helm

Frazier, one of just four black CEOs in the Fortune 500,  assumed a national profile in the US as he spoke out about race and racism, and left Trump's business ...

Pfizer expects to earn $15bn in 2021 from Covid-19 vaccine

Pfizer is commanding a higher price for its vaccine than some rivals

Ascendis operating profits jump amid Covid-19 demand

The health-focused group says its portfolio of assets has fared well during the pandemic

J&J obliged to send vaccine to US for fill and finish to EU’s ire

The process is part of the original contract but the EU sees it hampering its already slow Covid-19 vaccine rollout

J&J single-dose vaccine 72% effective in preventing Covid-19

In a sub-study of 6,000 volunteers in SA, the vaccine was 89% effective, with 95% of cases in the SA trial infected with the SA variant

Life Healthcare had trading bump just before SA’s second wave hit

Hospital occupancies enjoyed a healthy improvement in October and November as elective surgeries picked up

GE upbeat over 2021 outlook after free cash flow beats estimates

Company set an annual target for the key performance measure at $2.5bn-$4.5bn

Ascendis hints it may be able to hold onto crown jewel Remedica

Two lenders seem to have come to its rescue, offering the prospect of a recapitalisation without disposals


Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.